Adjuvant Capital

New York, New York
Founded:2012
Firm Location:New York, New York • San Francisco, California • Amsterdam, Netherlands • Germany • Melbourne, Australia
Adjuvant Capital Team
Photo of Joshua Adeoye, Associate at Adjuvant Capital
Joshua Adeoye
Adjuvant Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Kabeer Aziz, Principal at Adjuvant Capital
Kabeer Aziz
Adjuvant Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Michael Chang, Venture Partner at Adjuvant Capital
Michael Chang
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Lilly deSouza Burr, Principal at Adjuvant Capital
Lilly deSouza Burr
Adjuvant Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Philippe Dro, Partner at Adjuvant Capital
Philippe Dro
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Photo of Curt LaBelle, Venture Partner at Adjuvant Capital
Curt LaBelle
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Photo of Glenn Rockman, Managing Partner at Adjuvant Capital
Glenn Rockman
Adjuvant Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Impact (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Impact (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in New York City (Other Lists), Investors in Impact (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Impact (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Dimple Sahni, Investor at Adjuvant Capital
Dimple Sahni
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in Impact (Seed), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Mark Sullivan, Venture Partner at Adjuvant Capital
Mark Sullivan
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Melbourne (Australia)
Photo of Jenny Yip, Managing Partner at Adjuvant Capital
Jenny Yip
Adjuvant Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)